Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Gallbladder Perforation Associated with Consumption of Curcumin Case Report

Alejandro Vega B.A.*, Ernie Yap MD

State University of New York Medical Center, Brooklyn, NY 11203, USA

Abstract: Curcumin is an herbal supplement that is consumed for its purported anti-inflammatory, antioxidant, and antitumor properties as well as the prevention of gallstone formation. There have been few studies that investigate its role in people with current or history of biliary obstruction. Herein we discuss an encounter of a patient who presented with a perforated gallbladder after having ingested 1500-2250mg of curcumin per day for four months. We shall also review the state of known literature on the pharmacokinetic and pharmacodynamic profile of curcumin and its role as an herbal supplement. Lastly, we will examine the pitfalls of taking high levels of herbal supplements.

Keywords: Curcumin, adverse events, biliary obstruction, gallstone, perforation

Received November 01, 2022; Revised December 05, 2022; Accepted December 15, 2022

Citation: Alejandro Vega B.A., Ernie Yap MD, Gallbladder Perforation Associated with Consumption of Curcumin Case Report. American Journal of Medical Case Reports, 10 (12). 311-313. January 2022. doi:10.12691/ajmcr-10-12-4

1. Introduction

Curcumin is consumed worldwide as a nutritional supplement; with purported salutary effects on diabetes control, skin disorders, high cholesterol, Alzheimer disease, depression, HIV, upset stomach, joint pain, uveitis, osteoarthritis, rheumatoid arthritis, and generalized pain [1,2,3]. It is usually ingested in pill or powder form. There have been few adverse events recorded when curcumin was studied across a variety of diseases and diagnoses [1,2]. Despite being contraindicated in patients with biliary obstruction [4], its incidence and pathogenic mechanisms remain unclear. Gallbladder perforation (GBP) is considered a morbid condition because it is often diagnosed late [5]. The most common causes of GBP are gallstones and cholecystitis, and it is more common in elderly males within the Hispanic population [6,7]. Perforated gallbladders are a rare but serious complication of gallstones (2%-11%) [8]. Immediate surgical intervention is usually indicated, although some cases may resolve with supportive care [7]. We report a patient who ingested a large amount of curcumin and developed GBP.

2. Case Presentation

A 69-year old man came to the emergency department with non-exertional epigastric and chest pain, fever and diaphoresis for three days duration. The pain was described as 8/10 and radiated to his upper back bilaterally. On exam, he had mild epigastric tenderness to palpation. There was no costovertebral angle tenderness and he exhibited normal bowel sounds throughout. The cardiac and pulmonary exams were unremarkable. His past medical history included cholelithiasis, coronary artery disease and arterial hypertension. His medications include aspirin, rosuvastatin, fluoxetine, metoprolol succinate, and tamsulosin. He also attested to have been ingesting between 1500-2000mg of curcumin daily in powder and pill form for the last four months.

His laboratory values were significant for a white blood cell count of 13.3x10⁹/L (normal 4.5-11x10⁹/L) and a CA19-9 of 239 U/mL (normal 0-37 U/mL). Computed tomography (CT) of the chest was performed to evaluate for aortic dissection instead showed an acute perforated gallbladder with fluid collection measuring 3.8cm x 4.5 cm and 1 cm calcified stone at the neck of the gallbladder (Figure 1). A subsequent magnetic resonance image (MRI) also demonstrated a 1 cm gallstone within the neck of the gallbladder. The superior aspect of the gallbladder contained a multicystic collection.

Figure 1. Coronal CT image of the patient showing a perforated gallbladder

The patient was admitted for observation and given metronidazole 500 mg every 8 hours and levofloxacin 750 mg once daily. Over the next week, his pain improved and was discharged home on day 7 with a plan to complete his 14-day antibiotic regimen.

3. Discussion

Curcumin is consumed for its anti-inflammatory, antioxidant, and antitumor properties [2,3]. Curcumin is the main ingredient in turmeric. Turmeric is a perennial plant (Curcuma Longa) that is in the ginger family. It has been used for over 2000 years in China and India as a culinary supplement, medicine, cosmetic and fabric dye [3]. Johnson & Johnson currently manufactures curcumin band-aids in India [3]. Indian culture also uses it medicinally as “non-traditional medicine” by mixing it with boiled milk to suppress cough. It is even used for anti-hallucinatory effects against hashish [3].

Curcumin’s anti-inflammatory effects are attributed to its inhibition of COX2, NF-κB, STAT3 and CRP [3,9,10,11,12]. NF-κB is a transcription factor that plays a critical role in regulating the transcription of signals that are involved in acute and chronic inflammation [3,9,10]. Some other important downstream targets of NF-κB include cyclin D1, adhesion molecules, BCL-2 and also tumor necrosis factor (TNF). Curcumin may work by quenching reactive oxygen species to inhibit NF-κB [10]. Another study also indicated that curcumin abolished the phosphorylation and degradation of inhibitor of nuclear factor kappa B (IKB) induced by TNF, suggesting that the step in the signal transduction pathway of NF-κB activation inhibited by this agent precedes the phosphorylation step of NF-κB [13].

Curcumin has also been shown to slow cancer progression in animal trials [3,9,14,15]. Curcumin reduces tumors induced by benz(a)pyrene and 7,12 dimethylbenz(a)anthracene and decreases tumor promotion induced by phorbol esters on mouse skin [3]. Curcumin has been shown to inhibit cancer development initiated by N-ethyl-N’-nitro-N-nitrosoguanide-(MNNG) induced duodenal tumors and reduces the multiplicity of esophageal tumors and preneoplastic lesions in rats with N-nitromethylbenzylamine induced esophageal carcinogenesis [3,9,14,15]. In bladder cancer, curcumin showed a cytotoxic effect against the MBP-2 tumor line in rats and the UMUC tumor cell line in humans [3,9,14,15].

Curcumin has shown significant antioxidant properties by increasing the activity of phase II enzymes such as glutathione transferase and UDP-glucuronosyltransferase [16]. Phase II enzymes detoxify carcinogens present in cells. Curcumin has shown to increase the effects of cyclophosphamide in rats who were fed curcumin for 7 days [16].

Curcumin has shown to increase human gallbladder motility by 29% with a 20mg dose [17]. The standard dose for a pill or powder is 1500mg-2000mg [18]. It is contraindicated in patients with gallstones but has also shown to decrease gallstone formation in patients without a history of gallstones [19].

There have been few adverse event reports despite considerable curcumin consumption (1500mg to 2500mg 1-2 times per day) in patients with a variety of conditions including colorectal cancer, pancreatic cancer, Crohn disease, rheumatoid arthritis, gastric ulcers, vitiligo, psoriasis, diabetes and much more [1,2]. Curcumin has demonstrated to have low bioavailability in patients consuming 2200 mg of curcuma extract per day for four months, suggesting that larger clinical trials of high dose curcumin administration are merited [20]. Parenteral administration of curcumin demonstrated considerably more activity, suggesting why high oral doses have been well tolerated [21]. At 3600 mg consumption of curcumin per day, pharmacologically efficacious levels were achieved with little distribution outside of the gut [22]. Efficacy was measured by adenoma reduction load in animals [23].

We hypothesize that the perforated gallbladder could have occurred due to overdose of curcumin while having a preformed gallstone. Since curcumin increases gallbladder motility [17], the gallbladder will have more difficulty releasing a preformed gallstone because there is less space in the biliary tree for the gallstone to be released. The buildup of pressure from repeated curcumin consumption/gallbladder contraction without gallstone release eventually ruptured the gallbladder.

The benign presentation of the patient could be attributed to the anti-inflammatory properties of curcumin. It has been shown to accelerate healing in perforated nasal septum in animal models [24] and inhibits COX2 and NF-κB [3]. FLLL32, a curcumin analog, demonstrated downregulation of proinflammatory cytokines TNF-α, IL-6 and the TLR9 signaling pathway [25,26,27]. These characteristics conceivably attenuated the inflammatory response by the patient, which helped him avoid surgery.

This case is important because it highlights the potential dangers on over ingesting herbal supplements. Herbal supplements typically circumvent drug regulatory agencies [28] and it is estimated that only 1/100 adverse events with herbal supplements are reported [29].

Learning Points

- Curcumin should be used cautiously, especially in patients with biliary disorders.

- Adverse events due to herbal supplement use should be rigorously and systematically reported.

- More studies are needed to investigate the benefits and risks of curcumin supplementation in humans.

References

[1]   | Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. Mar 2012; 39(3): 283-99.
[2]   | Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. Jan 2013; 15(1): 195-218.
[3]   | Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. Jun 2008; 65(11): 1631-52.
[4]   | Woodland G. Turmeric: potential adverse effects and interactions. United Kingdom: NHS; 2018.
[5]   | Date RS, Thrumurthy SG, Whiteside S, et al. Gallbladder perforation: case series and systematic review. Int J Surg. 2012; 10(2): 63-8.
[6]   | Stefanidis D, Sirinek KR, Bingener J. Gallbladder perforation: risk factors and outcome. J Surg Res. Apr 2006; 131(2): 204-8.
[7]   | Derıcı H, Kamer E, Kara C, et al. Gallbladder perforation: clinical presentation, predisposing factors, and surgical outcomes of 46 patients. Turk J Gastroenterol. Oct 2011; 22(5): 505-12.
[8]   | Derici H, Kara C, Bozdag AD, Nazli O, Tansug T, Akca E. Diagnosis and treatment of gallbladder perforation. World J Gastroenterol. Dec 2006; 12(48): 7832-6.
[9]   | Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 10 2017; 6(10).
[10]   | Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. Jun 2009; 14(2): 141-53.
[11]   | Rao CV. Regulation of COX and LOX by curcumin. Adv Exp Med Biol. 2007; 595: 213-26.
[12]   | Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol. Jun 1973; 25(6): 447-52.
[13]   | Sung Eun K, Y oung-Pil Y, Kyu-Sik S, Daniel I. J, Kyeongsoon P, Hak-Jun K. In vitro and in vivo anti-inflammatory and tendon-healing effects in Achilles tendinopathy of long-term curcumin delivery using porous microspheres. Journal of Industrial and Engineering Chemistry; 2018, p. 123-130.
[14]   | Liu TY, Tan ZJ, Jiang L, et al. Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell Int. Jun 2013; 13(1): 64.
[15]   | Ono M, Higuchi T, Takeshima M, Chen C, Nakano S. Antiproliferative and apoptosis-inducing activity of curcumin against human gallbladder adenocarcinoma cells. Anticancer Res. May 2013; 33(5): 1861-6.
[16]   | Ak T, Gülçin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact. Jul 2008; 174(1): 27-37.
[17]   | Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther. Feb 1999; 13(2): 245-9.
[18]   | Turmeric. 2021.
[19]   | M.Sc. M.S H, M.Sc. PDN, Chandrasekhara. Influence of curcumin and capsaicin on cholesterol gallstone induction in hamsters and mice. Nutrition Research; 1993. p. 349-357.
[20]   | Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. Jul 2001; 7(7): 1894-900.
[21]   | Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. Feb 1991; 57(1): 1-7.
[22]   | Garcea G, Berry DP, Jones DJ, et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. Jan 2005; 14(1): 120-5.
[23]   | Perkins S, Verschoyle RD, Hill K, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. Jun 2002; 11(6): 535-40.
[24]   | Çakan D, Aydın S, Demir G, Başak K. The effect of curcumin on healing in an animal nasal septal perforation model. Laryngoscope. 10 2019; 129(10): E349-E354.
[25]   | Eckert J, Scott B, Lawrence SM, Ihnat M, Chaaban H. FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis. J Inflamm Res. 2017; 10: 75-81.
[26]   | Yılmaz Savcun G, Ozkan E, Dulundu E, et al. Antioxidant and anti-inflammatory effects of curcumin against hepatorenal oxidative injury in an experimental sepsis model in rats. Ulus Travma Acil Cerrahi Derg. Nov 2013; 19(6): 507-15.
[27]   | Li H, Sun H, Xu Y, Xing G, Wang X. Curcumin plays a protective role against septic acute kidney injury by regulating the TLR9 signaling pathway. Transl Androl Urol. May 2021; 10(5): 2103-2112.
[28]   | Langmead L, Rampton DS. Review article: herbal treatment in gastrointestinal and liver disease--benefits and dangers. Aliment Pharmacol Ther. Sep 2001; 15(9): 1239-52.
[29]   | Sharma V, Gelin LFF, Sarkar IN. Identifying Herbal Adverse Events From Spontaneous Reporting Systems Using Taxonomic Name Resolution Approach. Bioinform Biol Insights. 2020; 14: 1177932220921350.